Key Takeaways
- IMC uses metal isotope-tagged antibodies and laser ablation to image many proteins at about 1 µm resolution.
- Mass-based detection avoids the spectral overlap and autofluorescence that affect fluorescence multiplexing.
- Unlike suspension mass cytometry, IMC preserves spatial information in tissue.
- Antibody validation and panel design have a large influence on data quality.
- Sample preparation and image analysis affect results as much as acquisition does.
What Is Imaging Mass Cytometry?
Imaging mass cytometry combines metal-isotope-tagged antibody labeling with laser ablation and inductively coupled plasma time-of-flight mass spectrometry (ICP-TOF-MS). The resulting isotope signals are reconstructed into spatially resolved images showing where the selected protein markers occur in tissue.
The core workflow:
Prepare and label the tissue. Section the specimen, perform any required antigen-retrieval steps, and stain it using a validated panel of metal-tagged antibodies.
Laser-ablate selected regions. A focused laser scans across tissue regions in small sampling spots, commonly at approximately 1 µm spatial sampling in conventional IMC systems. The exact spot size and acquisition settings depend on the instrument.
Ionize and measure the material. The ablated material is transferred to an inductively coupled plasma, where it is atomized and ionized. Time-of-flight mass spectrometry measures the signals from the metal isotopes.
Reconstruct and analyze the images. Spatially registered isotope measurements are assembled into marker-specific image channels. Subsequent image processing, segmentation, and phenotyping may be used to analyze cellular organization.
IMC can be applied to both FFPE and fresh-frozen tissue, which allows retrospective studies of archived samples.
Why Location Matters in Proteomics
Expression data can show that a cell is positive for a marker. It cannot show whether that cell sits inside a tumor nest, at the invasive front, or in the stroma.
In a 2024 Cancer Cell study of non-small-cell lung cancer, researchers used imaging mass cytometry to investigate cancer-associated fibroblast (CAF) heterogeneity in tumors from 1,070 patients. The study employed a 45-antibody panel and identified 11 CAF phenotypes with distinct spatial distributions.
Using these phenotypes and their spatial patterns, the researchers identified four prognostic patient groups. These were patient classifications based on CAF features - not four categories into which the 11 CAF phenotypes were divided.
The observational findings included:
- Tumor-like CAFs: associated with poorer patient prognosis.
- Inflammatory and interferon-response CAFs: associated with more immune-inflamed tumor microenvironments and better survival.
- Matrix CAFs: higher density was associated with lower immune infiltration and poorer survival.
These associations demonstrate the importance of CAF phenotype and spatial context in the studied non-small-cell lung cancer cohort. They do not establish that a particular CAF population independently causes the observed clinical outcomes.
How Imaging Mass Cytometry Works
IMC uses lanthanide metal isotopes instead of fluorophores. Each isotope has its own mass channel, which avoids spectral bleed-through and tissue autofluorescence.
The acquisition sequence:
- Prepare and section the tissue.
- Stain with a validated metal-tagged antibody panel.
- Select regions of interest (ROIs).
- Ablate each ROI with the laser, spot by spot.
- Detect ions by mass spectrometry.
- Reconstruct the multichannel image.
Panel Size and Resolution Trade-offs
Conventional commercial IMC workflows commonly use antibody panels containing several dozen markers, often around 40, although the practical number depends on instrument capabilities, available isotopes, antibody conjugation, channel interference, and panel validation. The theoretical number of mass channels should not be confused with the number of reliably measurable proteins in a particular experiment.
A review of imaging mass cytometry described approximately 1 µm imaging resolution and acquisition of roughly 1 mm² in two hours for the instrument capabilities discussed. These are representative values from the reviewed technology, not universal specifications for all IMC systems or acquisition modes.
An approximately 1 µm pixel or sampling spot does not represent an independently measured single cell. Cell-level analyses require appropriate segmentation and interpretation of marker signals across multiple pixels. Because acquisition time scales with analyzed tissue area and sampling requirements, many IMC studies focus on selected regions of interest.
Jackson and colleagues used 35 isotope-conjugated antibodies across 720 images from 352 breast cancer patients (Nature, 2020). They linked the spatial structure of tumor cell communities to patient outcomes. Datasets of this size require careful panel design and consistent ROI selection.
IMC Compared with Other Spatial Proteomics Methods
The term "mass spectrometry imaging" covers several distinct techniques.
| Method | Detection approach | Spatial information | Main trade-off |
|---|---|---|---|
| IMC | Metal-isotope-tagged antibodies, laser ablation, ICP-TOF-MS | Typically around 1 µm sampling in conventional systems | Targeted antibody panel; destructive, area-dependent acquisition |
| Suspension mass cytometry | Metal-tagged antibodies measured in dissociated cells | Original tissue positions are not retained | Multiparameter single-cell phenotyping without an intact tissue map |
| MALDI-MSI | Matrix-assisted laser ionization of molecular species, generally without antibody labels | Resolution varies substantially by instrument and method | Broader molecular profiling, with analyte identification and ionization limitations |
| DESI-MSI | Ambient desorption electrospray ionization of molecular species | Resolution varies by sampling and instrument configuration | Label-free molecular imaging with assay-dependent spatial resolution |
| Cyclic immunofluorescence | Repeated fluorescence antibody staining, imaging, and signal removal | Optical resolution, with cell assignments dependent on segmentation | Multiple processing cycles, registration requirements, and potential autofluorescence |
| MIBI | Metal-tagged antibodies measured through ion-beam sampling and mass detection | Can achieve submicrometer spatial sampling, depending on system | Destructive sampling and instrument-dependent area throughput |
MALDI and DESI imaging are largely label-free and untargeted, detecting a broad range of biomolecules. IMC is targeted and depends on antibody specificity.
Compared with cyclic fluorescence methods, IMC avoids fluorescence-specific spectral overlap and tissue autofluorescence because it measures metal isotopes rather than emitted light. However, IMC has its own potential signal interference and acquisition limitations. Conventional IMC typically offers lower spatial resolution than suitable high-resolution optical fluorescence imaging, although actual performance depends on the instrument and analytical method.
Fluorescence image acquisition for a particular field can be faster than IMC sampling, but cyclic fluorescence workflows may require substantial additional time for repeated staining, imaging, signal removal, and registration. Total experiment duration should therefore be compared across the complete workflow rather than imaging speed alone.
MIBI also uses metal-tagged antibodies but employs ion-beam-based sampling instead of IMC's laser-ablation approach.
Method choice depends on the research objective:
- Broad molecular investigation: appropriately selected mass-spectrometry imaging approaches can measure molecular species without requiring a predefined antibody panel.
- Targeted spatial protein phenotyping: IMC and MIBI can map defined protein markers in tissue.
- Repeated optical multiplexing: cyclic fluorescence can provide detailed spatial imaging when staining, registration, and analysis requirements are supported.
Applications and Antibody Considerations
Common IMC applications include:
- Tumor microenvironment profiling: mapping relationships among tumor, stromal, and immune cells.
- Immune-cell phenotyping: characterizing infiltrate composition and distribution.
- Developmental biology: studying tissue organization, including the maternal-fetal interface.
- Drug-resistance research: comparing phenotypes in treated and untreated tissue.
Antibody Performance
IMC measures only what the antibody panel detects. Epitope specificity, FFPE compatibility, and tolerance of antigen-retrieval conditions all influence data quality. Panel development usually involves testing more candidate antibodies than are retained.
A common design practice is to assign low-abundance targets to higher-sensitivity isotope channels and stronger markers to lower-sensitivity channels. IMC does not use the signal amplification available in some IHC methods, so this pairing helps preserve weak signals.
Sample Preparation and Image Analysis
Results depend on steps before and after ablation as well as on acquisition itself.
Complementary region isolation. Some IMC studies require RNA or protein measurements from selected tissue compartments, such as a tumor margin, stromal region, or immune aggregate. Laser capture microdissection (LCM) can isolate corresponding material for separate molecular analysis.
However, IMC uses destructive laser ablation. Tissue already consumed during IMC acquisition cannot subsequently be recovered by LCM. Complementary workflows therefore commonly use aligned serial sections or compatible capture procedures performed before destructive imaging.
LCM-derived material is processed in separate downstream RNA-extraction, sequencing, or mass-spectrometry workflows. When multiple cells are captured together, their molecular measurements represent the pooled region rather than independent single-cell data or another continuous IMC image.
Laxco's Accuva Cellect Laser Capture Microdissection System provides:
- An infrared (IR) laser designed for film capture of single cells or small numbers of cells.
- An ultraviolet (UV) laser designed for cutting dense structures, such as bone or plant tissue.
- A five-step software workflow with visual quality control and documentation, using CapSure LCM caps.
- Documented support for FFPE and fresh-frozen tissue, H&E-stained and LCM-optimized stains, immunofluorescence, unstained samples, and cell culture.
Downstream image analysis. IMC generates spatially registered metal-isotope image channels that require assay-specific quality control, image reconstruction, segmentation, cell phenotyping, and spatial analysis. Appropriate processing methods must account for the characteristics of IMC data rather than assume that conventional fluorescence-image analysis is directly interchangeable.
Laxco's LEAP AI is a separate microscopy and image-analysis platform combining Accuva LEAP optics with Media Cybernetics Image-Pro AI. It supports segmentation, measurement, batch processing, and reporting through an Image → Process → Measure → Report workflow.
LEAP AI is not documented as a dedicated IMC analysis system. Its compatibility with native IMC multichannel datasets, specialized file formats, and IMC-specific analysis procedures must not be assumed.
Similarly, Accuva Cellect is a tissue-isolation instrument, not an imaging mass cytometer. Neither Cellect's capture workflow nor LEAP AI's microscopy-analysis workflow constitutes IMC acquisition or validated IMC-specific processing. Researchers should confirm compatibility separately before planning any combined study.
Frequently Asked Questions
How many proteins can IMC measure at once?
Commercial panels commonly include around 40 markers per acquisition. The practical number depends on isotope availability, mass overlap, and how many antibodies pass validation for the tissue type.
Is imaging mass cytometry compatible with FFPE tissue?
Yes. IMC can be applied to FFPE and fresh-frozen tissue, which allows retrospective studies of archived samples. Antibodies still need validation under the chosen fixation and antigen-retrieval conditions.
How does IMC compare with cyclic immunofluorescence?
IMC measures metal-isotope-tagged antibodies using laser ablation and mass spectrometry, avoiding fluorescence-specific spectral overlap and tissue autofluorescence. Conventional IMC typically operates at approximately 1 µm spatial sampling, while fluorescence microscopy can offer finer optical detail depending on the configuration.
Cyclic immunofluorescence builds larger marker panels through repeated staining, imaging, and signal-removal cycles. Individual fluorescence imaging rounds may be relatively fast, but total workflow duration depends on the number of cycles and processing requirements. IMC and cyclic fluorescence should therefore be compared on panel size, spatial resolution, tissue preservation, acquisition area, and full workflow time.
What support does Laxco provide for Accuva Cellect and LEAP AI?
Laxco lists training and 48-hour response times for the Accuva Cellect Laser Capture Microdissection System. The company also provides product and application information for LEAP AI, but the same response-time commitments or training formats should not be assumed for both products.
Confirm the available training options, technical-support arrangements, service terms, and response commitments separately with Laxco. Neither product is documented as a dedicated IMC platform, so researchers should also discuss any proposed cross-platform workflow before purchase.
